Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 8, 2013, Pages 1218-1226

  Ray, Charles E ^a   Edwards, Anthony ^a   Smith, Mitchell T ^a   Leong, Stephen ^a   Kondo, Kimi ^a   Gipson, Matthew ^a   Rochon, Paul J ^a   Gupta, Rajan ^a   Messersmith, Wells ^a   Purcell, Tom ^a   Durham, Janette ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; GELFOAM; GEMCITABINE; IODINATED POPPYSEED OIL; IRINOTECAN; MITOMYCIN; OXALIPLATIN; POLYVINYL ALCOHOL; STARCH MICROSPHERE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ANAPHYLACTIC SHOCK; ANEMIA; ANOREXIA; ARTERY SPASM; ARTICLE; BILE DUCT CARCINOMA; CANCER MORTALITY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHOLANGITIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG ELUTING BEAD; DRUG INDUCED DISEASE; DUODENUM ULCER; ECHOGRAPHY; EMBOLIC PARTICLE; FEVER; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEPATIC ARTERY SPASM; HEPATORENAL SYNDROME; HUMAN; HYPERGLYCEMIA; HYPERTENSIVE CRISIS; INOPERABLE CANCER; LIVER ABSCESS; LIVER FAILURE; LUNG EDEMA; LUNG INFARCTION; META ANALYSIS; NATIONAL HEALTH ORGANIZATION; NAUSEA; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PAIN; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; STOMACH ULCER; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; THROMBOCYTOPENIA; TIME TO TREATMENT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UPPER ABDOMINAL PAIN; UPPER GASTROINTESTINAL BLEEDING; WORLD HEALTH ORGANIZATION;

HCC; HEPATOCELLULAR CARCINOMA; RECIST; RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;

CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880746524     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.03.019     Document Type: Article

References (31)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD Cholangiocarcinoma. Lancet 2005; 366:1303-1314. Erratum in: Lancet 2006; 367:1656.
2. J.J. Zechlinski, and W.S. Rilling Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma Semin Intervent Radiol 30 2013 21 27
3. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
4. J.M. Llovet, M.I. Real, and X. Montaña Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial Lancet 359 2002 1734 1739
5. L. Marelli, R. Stigliano, and C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
6. Y.Z. Patt, M.M. Hassan, and A. Aguayo Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma Cancer 101 2004 578 586
7. J.B. Kuhlmann, W. Euringer, and H.C. Spangenberg Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy Eur J Gastroenterol Hepatol 24 2012 437 443
8. T.J. Vogl, N.N.N. Naguid, and N.E.A. Nour-Eldin Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success Int J Cancer 131 2011 733 740
9. S.Y. Park, J.H. Kim, H.J. Yoon, I.S. Lee, H.K. Yoon, and K.P. Kim Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma Clin Radiol 66 2011 322 328
10. S.C. Schiffman, T. Metzger, and G. Dubel Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival Ann Surg Oncol 18 2011 431 438
11. T. Andrasina, V. Valek, and J. Panek Multimodal oncological therapy comprising stents, brachytherapy, and regional chemotherapy for cholangiocarcinoma Gut Liver 4 suppl 2012 S82 S88
12. R. Chaiteerakij, G. Schmit, T.A. Mettler, J. Andrews, and L.R. Roberts Transarterial chemoembolization (TACE) improved survival in unresectable intrahepatic cholangiocarcinoma. 61st Annual Meeting of the American Association for the Study of Liver Diseases (abstr.) Hepatology 52 suppl 2010 1137A
13. M.V Kiefer, M. Albert, and M. McNally Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, Ethiodol, and polyvinyl alcohol: a 2-center study Cancer 117 2011 1498 1505
14. J. Harder, W. Euringer, M. Langer, R. Thimme, H.E. Blum, and H.C. Spangenberg Transarterial chemoembolization of intrahepatic cholangiocarcinomas with irinotecan-eluting beads: preliminary results. 60th Annual Meeting of the American Association for the Study of Liver Diseases (abstr.) Hepatology 50 suppl 4 2009 1116A
15. G. Poggi, A. Amatu, and B. Montagna OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma Cardiovasc Intervent Radiol 32 2009 1187 1192
16. C. Aliberti, G. Benea, T. Massimo, and G. Giorentini Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results Cardiovasc Intervent Radiol 31 2008 883 888
17. N.J. Gusani, F.K. Balaa, and A.L. Steel Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single institution experience J Gastrointest Surg 12 2008 129 137
18. J.H. Kim, H.K. Yoon, and K.B. Sung Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes Cancer 113 2008 1614 1622
19. K. Shitara, I. Ikami, M. Munakata, O. Muto, and Y. Sakata Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma Clin Oncol 20 2008 241 246
20. S. Herber, G. Otto, and J. Schnieder Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma Cardiovasc Intervent Radiol 30 2007 1156 1165
21. I. Burger, K. Hong, and R. Schulick Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution J Vasc Interv Radiol 16 2005 353 361
22. T. Kirchhoff, L. Zender, and S. Merkesdal Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver World J Gastroenterol 11 2005 1091 1095
23. S.R. Alberts, G.J. Gores, and G.P. Kim Treatment options for hepatobiliary and pancreatic cancer Mayo Clin Proc 82 2007 628 637
24. D. Mazhar, J. Stebbing, and M. Bower Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? Future Oncol 2 2006 509 514
25. T. Okusaka, H. Ishii, and A. Funakoshi Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer Cancer Chemother Pharmacol 57 2006 647 653
26. B.H. Dingle, R.B. Rumble, and M.C. Brouwers The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review Can J Gastroenterol 19 2005 711 716
27. J.W. Valle, H. Wasan, and P. Johnson Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - the UK ABC-01 Study Br J Cancer 101 2009 621 627
28. T. Okusaka, K. Nakachi, and A. Fukutomi Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan Br J Cancer 103 2010 469 474
29. R.T. Hoffmann, P.M. Paprottka, and A. Schon Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival Cardiovasc Intervent Radiol 35 2012 105 116
30. A. Saxena, L. Bester, T.C. Chua, F.C. Chu, and D.L. Morris Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option Ann Surg Oncol 17 2010 484 491
31. S.M. Ibrahim, M.F. Mulcahy, and R.J. Lewandowski Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study Cancer 113 2008 2119 2128